227 related articles for article (PubMed ID: 30221071)
1. Gene expression profiling and immune cell-type deconvolution highlight robust disease progression and survival markers in multiple cohorts of CTCL patients.
Lefrançois P; Xie P; Wang L; Tetzlaff MT; Moreau L; Watters AK; Netchiporouk E; Provost N; Gilbert M; Ni X; Sasseville D; Wheeler DA; Duvic M; Litvinov IV
Oncoimmunology; 2018; 7(8):e1467856. PubMed ID: 30221071
[TBL] [Abstract][Full Text] [Related]
2. Gene expression analysis in Cutaneous T-Cell Lymphomas (CTCL) highlights disease heterogeneity and potential diagnostic and prognostic indicators.
Litvinov IV; Tetzlaff MT; Thibault P; Gangar P; Moreau L; Watters AK; Netchiporouk E; Pehr K; Prieto VG; Rahme E; Provost N; Gilbert M; Sasseville D; Duvic M
Oncoimmunology; 2017; 6(5):e1306618. PubMed ID: 28638728
[TBL] [Abstract][Full Text] [Related]
3. Predictive and Prognostic Biomarkers in Patients With Mycosis Fungoides and Sézary Syndrome (BIO-MUSE): Protocol for a Translational Study.
Belfrage E; Ek S; Johansson Å; Brauner H; Sonesson A; Drott K
JMIR Res Protoc; 2024 Apr; 13():e55723. PubMed ID: 38436589
[TBL] [Abstract][Full Text] [Related]
4. The relevance of peripheral blood T-helper 1 and 2 cytokine pattern in the evaluation of patients with mycosis fungoides and Sézary syndrome.
Papadavid E; Economidou J; Psarra A; Kapsimali V; Mantzana V; Antoniou C; Limas K; Stratigos A; Stavrianeas N; Avgerinou G; Katsambas A
Br J Dermatol; 2003 Apr; 148(4):709-18. PubMed ID: 12752128
[TBL] [Abstract][Full Text] [Related]
5. Primary cutaneous T-cell lymphoma (mycosis fungoides and Sézary syndrome): part I. Diagnosis: clinical and histopathologic features and new molecular and biologic markers.
Jawed SI; Myskowski PL; Horwitz S; Moskowitz A; Querfeld C
J Am Acad Dermatol; 2014 Feb; 70(2):205.e1-16; quiz 221-2. PubMed ID: 24438969
[TBL] [Abstract][Full Text] [Related]
6. Measurement of Quality of Life in Patients with Mycosis Fungoides/Sézary Syndrome Cutaneous T-Cell Lymphoma: Development of an Electronic Instrument.
McCaffrey S; Black RA; Nagao M; Sepassi M; Sharma G; Thornton S; Kim YH; Braverman J
J Med Internet Res; 2019 Jan; 21(1):e11302. PubMed ID: 30617041
[TBL] [Abstract][Full Text] [Related]
7. MicroRNA expression in early mycosis fungoides is distinctly different from atopic dermatitis and advanced cutaneous T-cell lymphoma.
Ralfkiaer U; Lindahl LM; Litman T; Gjerdrum LM; Ahler CB; Gniadecki R; Marstrand T; Fredholm S; Iversen L; Wasik MA; Bonefeld CM; Geisler C; Krejsgaard T; Glue C; Røpke MA; Woetmann A; Skov L; Grønbæk K; Odum N
Anticancer Res; 2014 Dec; 34(12):7207-17. PubMed ID: 25503151
[TBL] [Abstract][Full Text] [Related]
8. The Use of Transcriptional Profiling to Improve Personalized Diagnosis and Management of Cutaneous T-cell Lymphoma (CTCL).
Litvinov IV; Netchiporouk E; Cordeiro B; Doré MA; Moreau L; Pehr K; Gilbert M; Zhou Y; Sasseville D; Kupper TS
Clin Cancer Res; 2015 Jun; 21(12):2820-9. PubMed ID: 25779945
[TBL] [Abstract][Full Text] [Related]
9. TOX Expression in Mycosis Fungoides and Sezary Syndrome.
Pileri A; Cavicchi M; Bertuzzi C; Righi S; Zengarini C; Sabattini E; Roncador G; Agostinelli C
Diagnostics (Basel); 2022 Jun; 12(7):. PubMed ID: 35885488
[TBL] [Abstract][Full Text] [Related]
10. Primary cutaneous T-cell lymphoma (mycosis fungoides and Sézary syndrome): part II. Prognosis, management, and future directions.
Jawed SI; Myskowski PL; Horwitz S; Moskowitz A; Querfeld C
J Am Acad Dermatol; 2014 Feb; 70(2):223.e1-17; quiz 240-2. PubMed ID: 24438970
[TBL] [Abstract][Full Text] [Related]
11. Molecular staging of lymph nodes from 60 patients with mycosis fungoides and Sézary syndrome: correlation with histopathology and outcome suggests prognostic relevance in mycosis fungoides.
Fraser-Andrews EA; Mitchell T; Ferreira S; Seed PT; Russell-Jones R; Calonje E; Whittaker SJ
Br J Dermatol; 2006 Oct; 155(4):756-62. PubMed ID: 16965425
[TBL] [Abstract][Full Text] [Related]
12. Survival, disease progression and prognostic factors in elderly patients with mycosis fungoides and Sézary syndrome: a retrospective analysis of 174 patients.
Lebowitz E; Geller S; Flores E; Pulitzer M; Horwitz S; Moskowitz A; Kheterpal M; Myskowski PL
J Eur Acad Dermatol Venereol; 2019 Jan; 33(1):108-114. PubMed ID: 30176169
[TBL] [Abstract][Full Text] [Related]
13. The Role of Tumor Microenvironment in Mycosis Fungoides and Sézary Syndrome.
Liu Z; Wu X; Hwang ST; Liu J
Ann Dermatol; 2021 Dec; 33(6):487-496. PubMed ID: 34858000
[TBL] [Abstract][Full Text] [Related]
14. Molecular profiling of TOX-deficient neoplastic cells in cutaneous T cell lymphoma.
Xu J; Huang H; Wang S; Chen Y; Yin X; Zhang X; Zhang Y
Arch Dermatol Res; 2020 Sep; 312(7):513-525. PubMed ID: 31676945
[TBL] [Abstract][Full Text] [Related]
15. Retrospective Analysis of 118 Patients With Cutaneous T-Cell Lymphomas: A Single-Center Experience.
Polgárová K; Polívka J; Kodet O; Klener P; Trněný M
Front Oncol; 2022; 12():884091. PubMed ID: 35747818
[TBL] [Abstract][Full Text] [Related]
16. Prevalence and severity of pruritus in cutaneous T cell lymphoma.
Vij A; Duvic M
Int J Dermatol; 2012 Aug; 51(8):930-4. PubMed ID: 22788808
[TBL] [Abstract][Full Text] [Related]
17. Long-term outcome of 525 patients with mycosis fungoides and Sezary syndrome: clinical prognostic factors and risk for disease progression.
Kim YH; Liu HL; Mraz-Gernhard S; Varghese A; Hoppe RT
Arch Dermatol; 2003 Jul; 139(7):857-66. PubMed ID: 12873880
[TBL] [Abstract][Full Text] [Related]
18. Mycosis fungoides-type cutaneous T-cell lymphoma (MF-CTCL) epidemiology and treatment pathway in Spain: new insights for an accurate description.
D'Agostino P; Kent A; Sharp E; Schmidt F; Turini M
Drugs Context; 2020; 9():. PubMed ID: 32821261
[TBL] [Abstract][Full Text] [Related]
19. Survival outcomes and prognostic factors in mycosis fungoides/Sézary syndrome: validation of the revised International Society for Cutaneous Lymphomas/European Organisation for Research and Treatment of Cancer staging proposal.
Agar NS; Wedgeworth E; Crichton S; Mitchell TJ; Cox M; Ferreira S; Robson A; Calonje E; Stefanato CM; Wain EM; Wilkins B; Fields PA; Dean A; Webb K; Scarisbrick J; Morris S; Whittaker SJ
J Clin Oncol; 2010 Nov; 28(31):4730-9. PubMed ID: 20855822
[TBL] [Abstract][Full Text] [Related]
20. The incidences of other primary cancers in patients with mycosis fungoides and Sézary syndrome.
Błażewicz I; Olszewska B; Stawczyk-Macieja M; Jaśkiewicz M; Nowicki RJ; Sokołowska-Wojdyło M
Postepy Dermatol Alergol; 2021 Apr; 38(2):289-294. PubMed ID: 34408597
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
